Barclays »

United Therapeutics Corporation shares owned by Barclays

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Barclays

Quarter filed Position value Share count Share price at filing
2013-03-31 $16M 255k 60.89
2012-12-31 $13M 240k 53.41
2012-09-30 $46M 815k 55.88
2012-03-31 $1.6M 34k 47.12
2011-12-31 $48M 1.0M 47.25
2011-09-30 $38M 1.0M 37.49
2011-06-30 $80M 1.4M 55.10
2011-03-31 $29M 434k 67.02
2010-12-31 $59M 938k 63.22

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Opt Put Option (QQQ)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple Opt Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Tesla Opt Put Option (TSLA)
Ishares Tr Fund (HYG)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
Visa (V)
Alphabet Opt Put Option (GOOG)

View all positions for Barclays

Top funds holding United Therapeutics Corporation

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
AQR Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Nuveen Asset Management

View all funds holding United Therapeutics Corporation